A trial of Moderna’s norovirus vaccine in the U.S. has been put on hold by the FDA over a reported case of neurological ...

The FDA paused Moderna's norovirus vaccine trial due to a neurological side effect. New U.S. health secretary Robert F.

Peruvian authorities Saturday declared a 90-day nationwide sanitary emergency due to the “unusual increase” in cases of Guillain-Barré Syndrome ... to worry about flu shots.

Recent health news highlights US FDA's hold on Moderna's norovirus vaccine trial due to a side-effect case, Robert F. Kennedy ...

LANSING, Mich. (WILX) - Roughly one-tenth of the workforce at the Centers for Disease Control and Prevention are expected to ...

The neurologist explains the link between Guillain-Barre Syndrome and paralysis, and the initial symptoms to watch out for.

Health News Live Updates: We you the latest in health and wellness, offering timely news, expert insights, and essential trends to keep you informed and empowered to make healthier decisions. Stay ...

In its fourth-quarter earnings report, Moderna’s revenue was down substantially from 2023. Separately, media reports reveal ...

Earnings: Discover insights into revenue shifts, cost reductions, 2027 product goals, RSV market strategies, and its broader ...

Reports fourth quarter revenues of $1.0 billion, GAAP net loss of $(1.1) billion and GAAP EPS of $(2.91); loss includes approximately $0.2 ...